Speaker - DDL2018

Pallav Shah

Professor of Medicine at Imperial College, London, Senior Consultant Physician the Royal Brompton Hospital, and Chelsea & Westminster Hospital

Professor Pallav Shah is currently Professor of Medicine at Imperial College, London, He is a Senior Consultant Physician the Royal Brompton Hospital, and Chelsea & Westminster Hospital. He qualified in Medicine at Guy’s Hospital Medical School, London and trained in pulmonology at the Royal Brompton Hospital.
Professor Shah is active in both the research and the development of new treatments. He has over 200 papers and several books – including his contribution as sectional editor of the thoracic section of Grays Anatomy (39th & 40th editions) and as sectional editor for respiratory section of the Oxford textbook of Medicine (6th edition). He also the author of an Atlas of Flexible Bronchoscopy and chief editor of Essentials of Clinical Pulmonology. He has also been involved in the HERMES education program for the European Respiratory Society
Dedicated to improving standards of care for patients, Professor Shah has been on national and global guideline groups and is a specialist advisor to the National Institute of Clinical Excellence (NICE) and the Commission on Human Medicines (Cardiovascular, Diabetes, Renal, Respiratory & Allergy Expert Advisory Group). Furthermore, he has been the course director of an interventional bronchoscopy course for the last 17 years which is aimed at training other specialists in some of the new evolving bronchoscopic treatments.
Professor Pallav Shah is experienced in the diagnosis and treatment of all aspects of respiratory disease. He is renowned for interventional bronchoscopy and its application to respiratory medicine, Professor Shah has pioneered bronchoscopic lung volume reduction for emphysema with devices such as the Zephyr endobronchial valves, endobronchial coils, Vapor treatment, and Intrabronchial valves. More recently he has been focused on the treatment of COPD with Vapor therapy, targeted nerve ablation and the novel Rejuvinair (cryospray) procedure for chronic bronchitis. He was also involved in the development of bronchial thermoplasty for asthma. He is also involved in the development of novel techniques for the ablation of peripheral lung tumours and performs a range of procedures including cryotherapy and the insertion of gold markers to enable treatment with the CyberKnife.